Therese Liechtenstein

Senior Investment Director

Therese Maria (Thera) Liechtenstein, PhD, is a Senior Investment Director in the Biotechnology team. Thera joined M Ventures in 2018. She was instrumental in the creation and financing of multiple companies of M Ventures portfolio, including FoRx Therapeutics and Anavo Therapeutics. Thera actively leads investments and represents M Ventures on the board of multiple portfolio companies. Previously Thera managed strategic projects for the Healthcare business of Merck KGaA, Darmstadt, Germany . Prior to Merck KGaA, Darmstadt, Germany Thera was a client relationship manager in the field of wealth preservation, at Industrie- & Finanzkontor Ets. Thera comes from an academic background receiving her PhD in Immuno-Oncology from University College London, an MSc in Biomedical Sciences from the University of Amsterdam, and a BA in Biology and Business studies from New York University.